Biocept releases salary data. CEO sees compensation fall -29%

Biocept just filed its annual proxy statement, which details the salary information of its key executives. In 2015, the company's CEO made 844,201.

The table is included below:

Name and Principal Position

Year

Salary
($) (1)

Bonus

($) (2)

Stock

Awards

($) (3)

Option

Awards

($)(3)

Non-equity

Incentive Plan

Compensation

($) (4)

Other

Compensation

($) (5)

Total ($)

Michael W. Nall

2015

362,202

(6)

337,168

101,500

(7)

43,331

(8)

844,201

President and Chief Executive Officer

2014

418,782

(6)

238,054

318,935

196,250

(7)

30,878

(8)

1,202,899

Veena Singh, M.D.

2015

292,129

(9)

222,413

63,042

(10)

577,584

SVP, Senior Medical Director

2014

26,668

(9)

88,552

115,220

Lyle J. Arnold, Ph. D.

2015

261,672

222,413

59,867

(13)

543,952

SVP R&D, Chief Scientific Officer

2014

246,108

(11)

25,000

(12)

121,408

51,380

443,896

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Biocept makes a similar move, sign up!

Other recent filings from the company include the following:

Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - May 15, 2017
Securities to be offered to employees in employee benefit plans - May 15, 2017
Biocept Reports First Quarter 2017 Financial Results - May 11, 2017
Biocept: With Respect To Restricted Awards, The Restricted Period Sha - May 5, 2017

Auto Refresh

Feedback